Physician profile
Dwayne Lee Roberts
NPI 1114923083
$2,894.55
in general payments reported to CMS, 2019-2025
20 companies · $1,135 in 2025
The $1,135 reported for 2025 was more than what 80% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $206 · 2020: $49.99 · 2022: $260 · 2023: $457 · 2024: $786 · 2025: $1,135.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,379.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,378.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $621.60 | 2024-2025 | Tepezza |
| Tarsus Pharmaceuticals, INC. | $389.68 | 2024-2025 | Xdemvy |
| Sun Pharmaceutical Industries INC. | $312.98 | 2019-2025 | Cequa |
| Oyster Point Pharma, INC. | $296.36 | 2022-2024 | Tyrvaya, Ryzumvi |
| Alcon Vision LLC | $279.19 | 2019-2025 | Rocklatan, Tryptyr, Clareon |
| Dompe US, INC. | $187.02 | 2024-2025 | Oxervate |
| Bausch & Lomb Americas INC. | $152.18 | 2023-2024 | Xiidra, Miebo, Vyzulta |
| Novartis Pharmaceuticals Corporation | $141.43 | 2019-2023 | |
| Horizon Therapeutics Plc | $131.21 | 2022 | |
| Coopervision INC. | $119.75 | 2023-2024 | Misight Contact Lens, Myday Contact Lens |
| Abbvie INC. | $60.04 | 2024 | |
| Shire North American Group INC | $48.07 | 2019 | |
| Harrow Eye, LLC | $29.75 | 2025 | Vevye |
| Regeneron Healthcare Solutions, INC. | $27.85 | 2025 | Eylea Hd, Eylea |
| Optos, INC. | $27.14 | 2019 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ocular Therapeutix, INC. | $18.46 | 2024 | Dextenza |
| Biotissue Holdings INC. | $15.18 | 2025 | |
| Sight Sciences, INC. | $14.93 | 2025 | Tearcare System |
| Mallinckrodt Hospital Products INC. | $12.00 | 2020 | |
| Travere Therapeutics, INC. | $9.73 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dwayne Roberts listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.